Kyowa Kirin Pharmaceutical Development Ltd clinical trials
Acquired by Kyowa Kirin Co., Ltd.
The registry lists 13 studies whose lead sponsor is Kyowa Kirin Pharmaceutical Development Ltd. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 13, 2026.
Registry sponsor names on this page
- Kyowa Kirin Pharmaceutical Development Ltd13 studies
Something wrong with this grouping? Tell us on the Kyowa Kirin Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 13 of 13. All Kyowa Kirin Co., Ltd. studies →
- Registry for Patients With X-Linked HypophosphatemiaRecruitingNCT03193476
Sponsor listed in the registry: Kyowa Kirin Pharmaceutical Development Ltd · Kyowa Kirin Pharmaceutical Development Ltd — acquired company within the Kyowa Kirin Co., Ltd. group
- A Study to Describe the Lived Experience of XLH for Adolescents at End of Skeletal GrowthCompletedNCT05181839
Sponsor listed in the registry: Kyowa Kirin Pharmaceutical Development Ltd · Kyowa Kirin Pharmaceutical Development Ltd — acquired company within the Kyowa Kirin Co., Ltd. group
- Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)CompletedNCT05455931
Sponsor listed in the registry: Kyowa Kirin Pharmaceutical Development Ltd · Kyowa Kirin Pharmaceutical Development Ltd — acquired company within the Kyowa Kirin Co., Ltd. group
- Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of AgeCompletedNCT04188964Phase 1/2
Sponsor listed in the registry: Kyowa Kirin Pharmaceutical Development Ltd · Kyowa Kirin Pharmaceutical Development Ltd — acquired company within the Kyowa Kirin Co., Ltd. group
- Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 YearsWithdrawnNCT01596426Phase 1
Sponsor listed in the registry: Kyowa Kirin Pharmaceutical Development Ltd · Kyowa Kirin Pharmaceutical Development Ltd — acquired company within the Kyowa Kirin Co., Ltd. group
- Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 YearsWithdrawnNCT01596413Phase 1
Sponsor listed in the registry: Kyowa Kirin Pharmaceutical Development Ltd · Kyowa Kirin Pharmaceutical Development Ltd — acquired company within the Kyowa Kirin Co., Ltd. group
- A UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLHCompletedNCT04819490
Sponsor listed in the registry: Kyowa Kirin Pharmaceutical Development Ltd · Kyowa Kirin Pharmaceutical Development Ltd — acquired company within the Kyowa Kirin Co., Ltd. group
- Naloxegol Drug Utilization Post Authorisation Safety StudyCompletedNCT02813148
Sponsor listed in the registry: Kyowa Kirin Pharmaceutical Development Ltd · Kyowa Kirin Pharmaceutical Development Ltd — acquired company within the Kyowa Kirin Co., Ltd. group
- Naloxegol Health Outcome Post Authorisation Safety StudyTerminatedNCT02813369
Sponsor listed in the registry: Kyowa Kirin Pharmaceutical Development Ltd · Kyowa Kirin Pharmaceutical Development Ltd — acquired company within the Kyowa Kirin Co., Ltd. group
- Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC PatientsCompletedNCT02099591Phase 1
Sponsor listed in the registry: Kyowa Kirin Pharmaceutical Development Ltd · Kyowa Kirin Pharmaceutical Development Ltd — acquired company within the Kyowa Kirin Co., Ltd. group
- Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.CompletedNCT03638440
Sponsor listed in the registry: Kyowa Kirin Pharmaceutical Development Ltd · Kyowa Kirin Pharmaceutical Development Ltd — acquired company within the Kyowa Kirin Co., Ltd. group
- Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 YearsCompletedNCT01596400Phase 1
Sponsor listed in the registry: Kyowa Kirin Pharmaceutical Development Ltd · Kyowa Kirin Pharmaceutical Development Ltd — acquired company within the Kyowa Kirin Co., Ltd. group
- Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLHCompletedNCT03920072Phase 3
Sponsor listed in the registry: Kyowa Kirin Pharmaceutical Development Ltd · Kyowa Kirin Pharmaceutical Development Ltd — acquired company within the Kyowa Kirin Co., Ltd. group